Identification of Novel Drug Molecules Against NS3-Like Helicase Enzyme of Alongshan Virus
Authors:
- Fizza GulFGFizza Gul
- Sajjad AhmadSajjad Ahmad
- Kalsoom KhanKKKalsoom Khan
- Rehana MasoodRMRehana Masood
- Farhan SiddiqueFSFarhan Siddique
- Mehvish BibiMBMehvish Bibi
- Salma Mohammed AljahdaliSASalma Mohammed Aljahdali
- Mohammad Abdullah AljasirMAMohammad Abdullah Aljasir
- Tabarak Sabah JassimTJTabarak Sabah Jassim
- Dong-Qing WeiDong-Qing Wei
- Muhammad IrfanMIMuhammad Irfan
- 6 December 2024
- journal article
- research article
- Published by Springer Nature in Molecular Biotechnology
- Vol. 67 (12) , 4449-4464
Abstract
Alongshan virus (ALSV) is a novel tick-borne virus associated with human diseases. The ALSV is a segmented flavivirus from the family Flaviviridae. It is currently considered as tick-borne arbovirus. There is a high incidence of fever and headache among patients with ALSV infection, and some patients also present with fatigue, coma, depression, nausea, myalgia/arthralgia, and skin rashes. Neither a licensed vaccine nor a drug is currently available to treat ALSV. The development of new, practical, and innovative therapeutic approaches is needed to overcome the emergence of the pathogen. Research on drugs remains a complex, time-consuming, and expensive. The field of drug development has undergone a revolution due to the use of computational approaches, which provide several benefits that speed up and improve the process of developing novel drugs. The goal of this study is to identify novel drug-like molecules against NS3-like helicase enzyme of Alongshan virus. Using molecular docking, the binding potential of the top three ligands to the specified target was determined. Molecular dynamic simulations were used to identify the stabilities of the best-docked conformations followed by energy calculations and ADMET analysis. Three potential and promising compounds were identified by performing structure-based virtual screening of non-structural protein 3 (NS3) like helicase of Alongshan virus. The best-docked complexes identified through virtual screening were BDC-23169381, BDB-26412846, BDB-2641954. All these compounds had good pharmacokinetics characteristics and were identified as drug like.Keywords
This publication has 45 references indexed in Scilit:
- A DFT and molecular docking study of xerantholide and its interaction with Neisseria gonorrhoeae carbonic anhydraseComputational Biology and Chemistry, 2022
- Electrophilicity index revisitedJournal of Computational Chemistry, 2022
- RNA helicases required for viral propagation in humans2021
- In silico methods and tools for drug discoveryComputers in Biology and Medicine, 2021
- Conserved motifs in the flavivirus NS3 RNA helicase enzymeWIREs RNA, 2021
- New isolate from Salvinia molesta with antioxidant and urease inhibitory activityDrug Development Research, 2021
- New naphthalene derivative for cost-effective AChE inhibitors for Alzheimer’s treatment: In silico identification, in vitro and in vivo validationComputational Biology and Chemistry, 2020
- Structural and molecular basis of the interaction mechanism of selected drugs towards multiple targets of SARS-CoV-2 by molecular docking and dynamic simulation studies- deciphering the scope of repurposed drugsComputers in Biology and Medicine, 2020
- Empirical Double‐Hybrid Density Functional Theory: A ‘Third Way’ in Between WFT and DFTIsrael Journal of Chemistry, 2019
- Small-Molecule Library Screening by Docking with PyRx2014